Literature DB >> 8019265

Fluoroquinolones in chronic obstructive pulmonary disease.

A Colville, M Knowles, D Large, J George, P Mustchin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8019265      PMCID： PMC2540370          DOI： 10.1136/bmj.308.6941.1437a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Antibiotics in chronic obstructive pulmonary disease.

Authors:  H Hosker; N J Cooke; P Hawkey
Journal:  BMJ       Date:  1994-04-02

2.  Dangers of oral fluoroquinolone treatment in community acquired upper respiratory tract infections.

Authors:  R J Körner; D S Reeves; A P MacGowan
Journal:  BMJ       Date:  1994-01-15

3.  Treatment of acute exacerbations of chronic obstructive airways disease--a comparison of amoxycillin and ciprofloxacin.

Authors:  G S Basran; J Joseph; A M Abbas; C Hughes; G S Tillotson
Journal:  J Antimicrob Chemother       Date:  1990-12       Impact factor: 5.790

4.  Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the community.

Authors:  J T Macfarlane; A Colville; A Guion; R M Macfarlane; D H Rose
Journal:  Lancet       Date:  1993-02-27       Impact factor: 79.321

5.  Comparative crossover assessment of serum bactericidal activity and pharmacokinetics of ciprofloxacin and ofloxacin.

Authors:  R Echols; M P Weinstein; B O'Keeffe; A Shah; A H Heller
Journal:  J Antimicrob Chemother       Date:  1994-01       Impact factor: 5.790
  5 in total
  1 in total

Review 1.  Guide to selection of fluoroquinolones in patients with lower respiratory tract infections.

Authors:  Wael E Shams; Martin E Evans
Journal:  Drugs       Date:  2005       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.